Biopharmaceutical company
Ongoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens
including breakpoints
Antibiotic resistance
Reimbursement issues for antibiotics
H.R. 4187, DISARM - Developing An Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014
Presidents Council of Advisors on Science and Technology (PCAST) and their recent report on antibiotic resistance
LPAD (Limited Population Antibacterial Drug) proposal
HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
TRACY SPICER ELIZABETH MACDONALD BARNETT AMY TEJRAL